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oxylipins in triglyceride-rich 
lipoproteins of dyslipidemic 
subjects promote endothelial 
inflammation following a high fat 
meal
Anita Rajamani1, Kamil Borkowski2, samir Akre  1, Andrea Fernandez1, John W. Newman  2,3,4, 
scott I. simon1 & Anthony G. passerini1
elevated triglyceride-rich lipoproteins (tGRL) in circulation is a risk factor for atherosclerosis. tGRL from 
subjects consuming a high saturated fat test meal elicited a variable inflammatory response in TNFα-
stimulated endothelial cells (EC) that correlated strongly with the polyunsaturated fatty acid (PUFA) 
content. This study investigates how the relative abundance of oxygenated metabolites of PUFA, 
oxylipins, is altered in TGRL postprandially, and how these changes promote endothelial inflammation. 
Human aortic EC were stimulated with TNFα and treated with TGRL, isolated from subjects’ plasma 
at fasting and 3.5 hrs postprandial to a test meal high in saturated fat. Endothelial VCAM-1 surface 
expression stimulated by tNFα provided a readout for atherogenic inflammation. Concentrations of 
esterified and non-esterified fatty acids and oxylipins in TGRL were quantified by mass spectrometry. 
Dyslipidemic subjects produced TGRL that increased endothelial VCAM-1 expression by ≥35%, and 
exhibited impaired fasting lipogenesis activity and a shift in soluble epoxide hydrolase and lipoxygenase 
activity. Pro-atherogenic TGRL were enriched in eicosapentaenoic acid metabolites and depleted in 
esterified C18-PUFA-derived diols. Abundance of these metabolites was strongly predictive of VCAM-1 
expression. We conclude the altered metabolism in dyslipidemic subjects produces TGRL with a unique 
oxylipin signature that promotes a pro-atherogenic endothelial phenotype.
Disorders of metabolism are accompanied by an elevated systemic inflammatory state that accelerates the progression 
of atherosclerotic cardiovascular disease (CVD), the leading cause of death and disability in our society1,2. 
One-third of Americans are clinically categorized at higher risk for CVD in that they show a cluster of risk factors 
associated with high fat western diet and sedentary lifestyle defined as metabolic syndrome3. Among these risk 
factors is hypertriglyceridemia, which is characterized by elevated levels of serum triglycerides, circulating in 
ApoB-containing triglyceride-rich lipoprotein (TGRL). Elevated TGRL is a strong predictor for CVD4–7, and its 
uptake by the endothelium leads to inflammation that precedes and promotes atherosclerosis. Here we investigate 
how changes in the relative abundance of fatty acid metabolites circulating in TGRL link to its ability to prime an 
inflammatory response to a high fat meal.
Atherosclerosis has been proposed to be a postprandial process that is tied to transient elevation of postpran-
dial triglycerides8,9. A high fat meal induces a postprandial inflammatory state, characterized by elevated levels of 
circulating TGRL and other inflammatory mediators, including cytokines (e.g. TNFα) that promote endothelial 
dysfunction accompanying atherosclerosis. A high-fat test meal challenge has been established as an effective tool 
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to elicit inflammation of arterial endothelium and subsequent monocyte capture, changes not typically observed 
under fasting conditions. Therefore, a postprandial response may provide greater insight into the effects of metab-
olism on insipient inflammation than the fasting state10,11. We have investigated the capacity of TGRL produced 
by human subjects after consuming a high saturated fat meal, typical of western diet, to elicit a pro-atherogenic 
endothelial response.
Among the earliest inflammatory responses by the endothelium that precedes atherosclerosis is the acute 
upregulation of cell adhesion molecules (CAMs), notably vascular cell adhesion molecule (VCAM-1), the pre-
dominant receptor for monocyte recruitment from the circulation4,12. VCAM-1 expression correlates with cor-
onary lesion severity in atherosclerotic patients, and is causative in mouse models of atherosclerosis13,14. We 
showed that TGRL isolated from subjects after a standardized fast food breakfast meal high in saturated fat, can 
prime either a pro- or anti-atherogenic state, defined as a net up- or down-regulation of VCAM-1 expression 
in TNFα-stimulated human aortic endothelial cells (HAEC)15–18. In these studies, the level of VCAM-1 expres-
sion was strongly associated with the relative capacity to induce recruitment of monocytes from healthy subjects 
assessed in TNFα-inflamed HAEC16. The capacity for TGRL to alter VCAM-1 expression correlated closely with 
an individual’s metabolic status as reflected by their level of postprandial triglycerides and abdominal obesity. 
However, TGRL obtained from the same individuals when fasting did not prime inflamed HAEC for increased 
VCAM-1 expression15. Unknown is how the composition of TGRL is altered postprandially following the high 
fat meal to elicit a distinct endothelial inflammatory response by individuals exhibiting metabolic risk factors.
Dietary fatty acids of all saturation levels are packaged into and circulated by TGRL, which consist of chylo-
microns and VLDL, synthesized in the gut and liver respectively8. The fatty acid composition of circulating TGRL 
thus reflects both the content of a meal and an individual’s overall metabolic state, including the presence of dia-
betes or dyslipidemia19. We previously reported that pro- and anti-atherogenic TGRL were composed of distinct 
fatty acid profiles, and that pro-atherogenic TGRL in particular was enriched in non-esterified polyunsaturated 
fatty acids (PUFA)16. Though overall less abundant in TGRL, PUFA and their oxygenated metabolites, oxylipins, 
are potent mediators of inflammation20. PUFA are metabolized by three main enzymatic pathways to produce an 
array of oxylipins: cyclooxygenases (COX), lipoxygenases (LOX), and cytochrome P450s (CYP). COX-derived 
prostaglandins are generally considered pro-inflammatory. While LOX-derived mid-chain alcohols, leukotrienes, 
and ketones can be either pro- or anti-inflammatory (depending on the LOX isoform, the parent fatty acid and 
hydroxylation position), CYP-derived epoxides are considered anti-inflammatory. However, epoxides are readily 
hydrolyzed by soluble epoxide hydrolase (sEH) to form diols, which are reported to promote or have a neutral 
effect on inflammation20. Fatty acids and oxylipins are found in both esterified (bound) and non-esterified (free) 
pools in TGRL, and can be released by the action of lipases or upon receptor-mediated uptake by endothelial cells 
(EC)21.
Although 90% of oxylipins are esterified in lipoproteins, their exact origins are unclear, and the significance of 
their transport within lipoproteins is largely unknown. It has been demonstrated that diet and metabolism affect 
oxylipin abundance and distribution among lipoprotein pools. For example, plasma oxylipins were enriched in 
proportion to the fatty acid composition of a high-fat meal10,11. Metabolic syndrome is associated with a disrup-
tion of the oxylipin pattern across all lipoprotein classes that was putatively pro-inflammatory, and was mitigated 
by prescription omega-3 PUFA intervention22. Moreover, there is evidence that oxylipin metabolism can directly 
affect atherosclerosis. For example, inhibition of sEH reduced atherosclerosis in ApoE null mice on a high fat diet, 
which correlated with enrichment in the plasma epoxide to diol ratio23. We address whether oxylipins circulating 
in TGRL act to exacerbate endothelial inflammatory responses promoting atherosclerosis.
The objective of the current study was to identify, using an unbiased metabolomics approach, novel fatty 
acid constituents that can significantly predict the pro- or anti-atherogenic postprandial response after uptake 
and processing of an individual’s TGRL by endothelium. We hypothesized that metabolic dysregulation in dys-
lipidemic individuals is associated with a unique fasting and postprandial TGRL oxylipin signature in response 
to a high fat test meal. We report that the composition of sEH-derived diols and LOX-derived alcohols in post-
prandial TGRL strongly discriminated the response to the meal between pro- and anti-atherogenic subjects. 
A postprandial oxylipin signature was identified in pro-atherogenic subjects, characterized by enrichment in 
eicosapentaenoic acid (EPA) metabolites and depletion of esterified sEH-derived diols. Moreover, fasting indices 
of lipogenesis activity and the abundance of sEH-derived diols in TGRL were the best predictors of enhanced 
VCAM-1 expression.
Results
Plasma markers of dyslipidemia correlate with TGRL priming of HAEC inflammation. To eval-
uate the capacity of TGRL to mediate an inflammatory response in arterial endothelium, we examined a cohort 
of 39 subjects, characterizing each individual by their anthropometric, lipid, and metabolic characteristics, fast-
ing and 3.5 hrs after the high fat test meal (Supplementary Table S1). Subjects exhibited a broad range in BMI 
(19.81–30.25 kg/m2) and waist circumference (24.5–43.0 in), and ranged from normal to hypertriglyceridemic 
(fasting triglycerides 30–279 mg/dl). We measured the capacity of postprandial TGRL isolated from each subject’s 
plasma to alter TNFα-stimulated CAM surface expression in HAEC in an ex vivo assay. An increase in VCAM-1 
surface expression from stimulation with a low dose of TNFα (EC50 = 0.3 ng/ml) correlated most strongly with 
the postprandial spike in triglyceride levels (ΔTG = postprandial - fasting) (Fig. 1). Notably, postprandial TGRL 
isolated from subjects whose triglycerides increased >120 mg/dl in response to the meal routinely increased 
TNFα-stimulated VCAM-1 surface expression. In contrast, postprandial TGRL from those subjects in whom 
triglycerides increased <120 mg/dl reduced or had a neutral effect on TNFα-stimulated VCAM-1 surface expres-
sion in HAEC (Fig. 1a, inset). Each increase in plasma triglycerides of 100 mg/dl corresponded to a 12.5% increase 
in TNFα-stimulated VCAM-1 expression. In contrast, the change in triglycerides did not alter the inflammatory 
upregulation of ICAM-1 expression across subjects, which tended to be less variable (Fig. 1b, inset).
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In order to evaluate changes in the composition of TGRL that correlate most strongly with a characteristic 
postprandial inflammatory response in HAEC, five individuals were selected for metabolomics analysis from 
this cohort whose TGRL produced a pro-atherogenic (pro-) response, eliciting the greatest increase in VCAM-1 
surface expression (47.4 ± 22.5%) and expressing a ΔTG > 120 mg/dl. Another five subjects were selected whose 
Figure 1. Postprandial TGRL modulates VCAM-1 surface expression in endothelial cells in proportion to 
an individual’s postprandial change in triglycerides. Human aortic endothelial cells (HAEC) were treated 
with TNFɑ (0.3 ng/ml) in the presence or absence of postprandial TGRL (10 mg/dl ApoB) for 4 hr, and CAM 
surface expression quantified by flow cytometry and reported relative to TNFα stimulation alone. (a) VCAM-1 
expression across all subjects (black, N = 39) significantly correlated with the change in serum triglycerides in 
response to the meal. A threshold for change in plasma triglycerides (ΔTG, postprandial - fasting) >120 mg/
dl distinguished the capacity of a subject’s TGRL to elicit an increase in VCAM-1 surface expression (inset). (b) 
There was no such correlation with ICAM-1 expression. (c) Postprandial TGRL from pro-atherogenic subjects 
(red, n = 5) significantly enhanced VCAM-1 expression compared to anti-atherogenic subjects (blue, n = 5), but 
did not differ with respect to their effect on ICAM-1 expression.
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TGRL produced an anti-atherogenic (anti-) response, eliciting the greatest decrease in VCAM-1 surface expression 
(40.2 ± 19.5%) and expressing a ΔTG < 120 mg/dl (Fig. 1c). The subject characteristics and response to the meal 
are reported in aggregate (Supplementary Table S2) for comparison to the larger study cohort (Supplementary 
Table S1). On average triglycerides more than doubled in these subjects after the meal. Consistent with the larger 
study cohort all subjects exhibited substantially increased TG:HDL ratio and TC:HDL ratio 3.5 hrs postprandial 
compared to fasting. Postprandial TGRL did not significantly alter the TNFα-stimulated increase in ICAM-1 
surface expression, which is consistent with previous studies16,17 (Fig. 1c).
We next compared anthropometric characteristics, lipid, and metabolic profiles between these same 10 
subjects stratified into pro- and anti-atherogenic responders (Table 1). Consistent with our previous studies, 
pro-atherogenic subjects were distinguished by markers of abdominal obesity (higher BMI and waist circum-
ference), and enrichment in ApoB containing lipoproteins (notably triglycerides), accompanied by lower HDL, 
both fasting and postprandial. Subjects did not meet the clinical criteria for metabolic syndrome24 since waist cir-
cumference, fasting glucose, and blood pressure were within normal ranges. The modulation of TNFα-stimulated 
VCAM-1 surface expression by postprandial TGRL in these subjects correlated directly with fasting triglycerides, 
TG:HDL, ApoB, TC:HDL, and inversely correlated with HDL (Table 2). This is noteworthy since TGRL isolated 
from subjects after an overnight fast did not itself alter endothelial inflammation. Therefore, in the following 
investigation into the effect of the meal on pro- and anti-atherogenic TGRL composition, oxylipin and fatty acid 
abundance are expressed as a ratio of postprandial/ fasting. In contrast to VCAM-1, changes in ICAM-1 surface 
expression did not correlate with any clinical indicators of dyslipidemia.
A high fat meal challenge exacerbates a postprandial inflammatory state in pro-atherogenic 
subjects. To further characterize the differences in postprandial inflammatory state in dyslipidemic subjects 
eliciting a pro-atherogenic response, a panel consisting of cytokines and other markers of systemic inflammation 
was measured in plasma. Postprandial plasma levels of CRP, IFNγ, s-VCAM-1, and IL-6 were all significantly 
elevated in concert with a subject’s TGRL-dependent rise in endothelial VCAM-1 surface expression (Table 3). 
Among the inflammatory markers, an increase in CRP levels in response to the meal was most indicative of the 
pro-atherogenic endothelial response (Spearman’s ρ = 0.7, p = 0.03). Elevated CRP levels in both the fasting and 
postprandial states strongly discriminated between pro- and anti-atherogenic subjects (Supplementary Fig. S1), 
Physical, Non-metabolic Anti-atherogenic Pro-atherogenic p-value
Age (yrs) 47.4 ± 22.51 40.2 ± 19.51 0.52
BMI (kg/m2) 23.66 ± 2.57 30.5 ± 4.37 0.02
Waist circumference (cm) 86.11 ± 12.42 93.35 ± 8.26 0.02
Hip circumference (cm) 89.28 ± 5.13 101.35 ± 5.13 0.14
WHR 0.96 ± 0.02 0.92 ± 0.05 0.09
Systolic (mmHg) 116.2 ± 5.02 124.4 ± 8.68 0.1
Diastolic (mmHg) 71.2 ± 9.23 77.6 ± 12.46 0.21
Metabolic, Non-lipid
Glucose- fasting (mg/dl) 88.2 ± 6.06 85.2 ± 6.83 0.6
Glucose- postprandial (mg/dl) 82.6 ± 6.95 75.2 ± 13.08 0.3
Metabolic, Lipid
Fasting
HDL (mg/dl) 63.4 ± 14.31 42.4 ± 12.4 0.06
LDL (mg/dl)1 109 ± 33.89 198 ± 157.77 0.14
TC:HDL 2.94 ± 0.36 6.56 ± 2.68 0.01
TG (mg/dl) 64.4 ± 11.08 191.4 ± 79.69 0.01
ApoB (mg/dl) 71.2 ± 15.35 144 ± 90.71 0.01
Non-HDL-C (mg/dl) 122 ± 34.45 236.4 ± 154.41 0.04
TC (mg/dl) 185.4 ± 46.32 278.8 ± 160.24 0.21
TG:HDL 1.08 ± 0.43 4.93 ± 3.1 0.01
Postprandial
HDL (mg/dl) 63.2 ± 14.79 39.6 ± 10.09 0.05
TC:HDL-C 2.96 ± 0.37 6.86 ± 2.84# 0.01
TG (mg/dl) 122.8 ± 32.15# 400.4 ± 223.29# 0.01
ApoB (mg/dl) 74.83 ± 21.83 148.4 ± 86.6 0.02
Non-HDL-C (mg/dl) 124.6 ± 39.01 236.2 ± 159.35 0.1
TC (mg/dl) 187.8 ± 52.08 275.8 ± 164.97 0.25
TG:HDL 2.04 ± 1.34# 10.32 ± 1.34# 0.01
Table 1. Anthropometric, lipid, and metabolic characteristics of subjects selected for metabolomics profiling 
stratified into anti- and pro- atherogenic responders. Mean ± SD, n = 5 per group. P-values for pro- vs. anti- 
comparison performed using Wilcoxon signed rank test. 1Postprandial LDL levels could not be calculated for 
the majority of subjects due to elevated triglycerides. #Significant change postprandial to fasting within group.
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consistent with its utility as a general biomarker of inflammation and cardiovascular risk25. Moreover, elevated 
CRP levels of this magnitude in metabolic syndrome were associated with increased liver enzyme activity26,27. 
Also notable was that the postprandial change in s-VCAM-1, but not s-ICAM-1, in plasma correlated directly 
with a subject’s TGRL-mediated atherogenic phenotype in the ex vivo assay, in which pro-TGRL enhanced 
endothelial VCAM-1, but not ICAM-1 surface expression (Fig. 1c). Together these data confirm that VCAM-1 
upregulation in HAEC and in the circulating plasma are faithful inflammatory biomarkers that correlate with 
clinical measurers of dyslipidemia and metabolic dysregulation in the subject cohort.
A meal in high saturated fat increases n-6 oxylipins in circulating TGRL. We next investigated 
whether the high fat test meal elicited an effect on specific classes of fatty acids or oxylipins across all subjects. The 
complete composition of the test meal is found in the supplement (Supplementary Table S3). A previous analysis 
of the postprandial composition of TGRL that was limited to parent fatty acids, revealed enrichment in PUFA in 
pro-TGRL16. Since PUFA are readily metabolized, this motivated a more detailed unbiased mass spectrometry 
analysis of the abundance of PUFA-derived oxylipins in addition to PUFA, SFA, and MUFA in fasting and post-
prandial TGRL. We identified 22 of 153 metabolites that changed significantly in response to the meal. The results 
are reported separately for the esterified and non-esterified pools, superimposed on network maps displaying 
the enzymes and parent fatty acids specific to each metabolite (Figs 2 and 3). Among the SFA, the test meal sub-
stantially increased the ratio of stearic (C18:0) to palmitic acid (C16:0) (Fig. 2), reflecting the higher abundance 
of stearic acid in the meal. An overload of SFA in response to the test meal was also evident as a decrease in 
the ratio of MUFA to SFA, particularly MUFAs derived from palmitic and stearic acids. In the esterified PUFA 
categories, there was significant postprandial reduction in abundance of several n-3 PUFAs, particularly doco-
sahexaenoic acid (DHA), docosapentaenoic acid (DPA), and eicosapentaenoic acid (EPA), and in n-6 PUFA, 
dihomo-γ-linolenic acid (DGLA). There was a remarkable increase in abundance of sEH-derived oxylipins in 
response to the meal in both the esterified and non-esterified pools (Figs 2 and 3). Specifically, 12,13-dihydroxy 
octadecaenoic acid (12,13-DiHOME), 9,10-dihydroxy octadecaenoic acid (9,10-DiHOME), and 15,16-dihydroxy 
octadecadienoic acid (15,16-DiHODE) postprandially increased in abundance in both the esterified and 
non-esterified pools. The changes in the composition of the non-esterified pool were predominantly associated 
with sEH- and LOX-derived oxylipins originating from the C18 PUFA, linoleic (LA) and alpha-linolenic acid 
(ALA) (Fig. 3). These results highlight characteristic changes in the composition of TGRL after a meal high in 
saturated fat, including enrichment in diols and mid-chain alcohols that may mediate inflammation.
Factor Spearman’s ρ P-value (two tailed)
Physical, non-metabolic
Hip circumference (cm) 0.68 0.03
Body mass index (kg/m2) 0.75 0.01
Systolic (mmHg) 0.63 0.05
Measures of dyslipidemia
Triglycerides (mg/dl) 0.87 0.001
TG:HDL 0.84 0.002
ApoB (mg/dl) 0.77 0.01
TC:HDL 0.75 0.01
HDL (mg/dl) −0.65 0.04
Table 2. Correlation of endothelial VCAM-1 surface expression in response to postprandial TGRL with subject 
(n = 10) anthropometric characteristics and fasting measures of lipid metabolism.










Table 3. Correlation of endothelial VCAM-1 surface expression in response to postprandial TGRL with fold 
increase in abundance (postprandial/ fasting) of subject (n = 10) cytokine and inflammatory biomarker levels. 
IL-1α levels were undetectable. *Significant difference.
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sEH-derived diols and LOX-derived alcohols discriminate the response to the meal between 
pro- and anti-atherogenic subjects. To identify the differences in relative abundance of fatty acids and 
oxylipins in pro- vs. anti-atherogenic TGRL in response to the meal, a multivariate partial least squares discrimi-
nant analysis (PLS-DA) was performed. Postprandial levels of each constituent were normalized by fasting levels 
Figure 2. Network map depicting the fatty acids and metabolites measured in the esterified pool of TGRL. 
Superimposed in color are the fold change for fatty acids and oxylipins identified as significantly enriched (red) 
or depleted (blue) postprandially over all subjects. Colored arrows depict significant changes in the ratio of the 
abundance of the metabolites connected. Black boxes indicate metabolites that were detected but unchanged 
by the meal. White boxes are metabolites that were part of the analysis but not detected. Significance was 
determined using a two factor ANOVA comparing fasting to postprandial in the same subjects, and accounting 
for pro- and anti-atherogenic response. A Benjamini-Hochberg FDR multiple test correction was applied.
7Scientific RepoRts |          (2019) 9:8655  | https://doi.org/10.1038/s41598-019-45005-5
www.nature.com/scientificreportswww.nature.com/scientificreports/
for each individual (postprandial/ fasting) to adjust for baseline metabolic variation. Oxylipins yielded the strong-
est discrimination between the pro- and anti-TGRL samples (Q2 = 0.32) (Fig. 4). In contrast, discrimination was 
not achieved with the addition of the abundance of parent fatty acids to the analysis. The scores plot displays 
the separation between the pro- and anti-atherogenic TGRL groups, and the loadings plot superimposes the 22 
Figure 3. Network map depicting the fatty acids and metabolites measured in the non-esterified pool of TGRL. 
Superimposed in color are the fold change for fatty acids and oxylipins identified as significantly enriched (red) 
or depleted (blue) postprandially over all subjects. Colored arrows depict significant changes in the ratio of the 
abundance of the metabolites connected. Black boxes indicate metabolites that were detected but unchanged 
by the meal. White boxes are metabolites that were part of the analysis but not detected. Significance was 
determined using a two factor ANOVA comparing fasting to postprandial in the same subjects, and accounting 
for pro- and anti-atherogenic response. A Benjamini-Hochberg FDR multiple test correction was applied.
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oxylipins that contributed significantly to the separation. Differential enrichment in the free to bound oxylipin 
pools (indicated by solid versus open circles) emerged as a major trend distinguishing pro-TGRL. Mapping to the 
enzymatic pathways, distinguished by distinct color coding, revealed that postprandial change in non-esterified 
sEH-derived diols was a strong differentiator between pro- and anti-atherogenic subjects. Specifically, 
9,10-DiHOME, 14,15-dihydroxy eicosatrienoic acid (14,15-DiHETrE), and 19,20-DiHDoPE contributed maxi-
mally to the discrimination of pro- and anti-atherogenic subjects in the analysis (Fig. 4). LOX-derived metabolites 
also contributed to the discrimination of subjects, including non-esterified alcohols such as 5-hydroxy eicosap-
entaenoic acid (5-HEPE), 9-HOTE, and 9-HODE. This analysis revealed an interdependence of the effect of the 
meal and the atherogenic phenotype of the subject on TGRL composition.
To further evaluate the involvement of these 22 oxylipins in mediating a differential response to the meal, 
they were grouped into 4 clusters based on similar patterns of expression. Non-esterified diols and alcohols of 
C18-PUFA LA and ALA in cluster 1, represented by 9-HODE, were enriched to a greater extent postprandi-
ally in pro-atherogenic TGRL. Oxylipins in clusters 2 and 3, represented by non-esterified 5,6-DiHETrE and 
19,20-DiHDoPE, respectively, consisted primarily of diols and alcohols of C20- and C22-PUFA, which were 
highly expressed in the fasting state in anti-atherogenic TGRL. These same metabolites were depleted in the 
postprandial state of anti-atherogenic subjects (Supplementary Fig. 2). In contrast, esterified diols derived from 
C18-PUFA LA and ALA (cluster 4), represented by 15,16-DiHODE, were enriched to a greater extent postpran-
dially in anti-atherogenic TGRL. Consistent with the lack of inflammatory response induced by fasting TGRL in 
altering VCAM-1 expression, PLS-DA analysis did not discriminate pro-atherogenic from anti-atherogenic sub-
jects when using the abundance of fatty acids and oxylipins in fasting TGRL alone. Together these data implicate 
heterogeneity of LOX and sEH activity in subjects producing TGRL that elicit differential inflammatory responses 
to the same high fat meal.
VCAM-1 surface expression correlates strongly with the postprandial change in estimated 
seH activity. A striking finding was that dyslipidemic subjects displayed a unique shift in abundance of 
Figure 4. sEH-derived diols and LOX-derived alcohols strongly discriminate the response to the meal between 
pro- and anti-atherogenic subjects. PLS-DA analysis of postprandial TGRL samples characterized as pro- and 
anti-atherogenic (5 per group), using postprandial oxylipin abundance adjusted by fasting levels in the same 
individuals (postprandial/ fasting). The scores plot reveals the separation between pro-  and anti-atherogenic-
TGRL  (Q2 = 0.32). The PLS-DA model was constructed using all detected oxylipins. The loadings plot 
displays the 22 oxylipins that contributed significantly to discrimination between the groups (VIP > 1). The size 
of the circles corresponds to the VIP score. Each oxylipin is color coded by the enzyme from which it is derived.
9Scientific RepoRts |          (2019) 9:8655  | https://doi.org/10.1038/s41598-019-45005-5
www.nature.com/scientificreportswww.nature.com/scientificreports/
sEH-derived diols and LOX-derived alcohols in response to the meal compared to normolipidemic subjects. We 
next investigated whether these subjects exhibited differences in the activity of enzymes including LOX, COX, 
CYP, and sEH that could account for the observed range in ex vivo VCAM-1 response. Indices of enzyme activity 
were calculated as a ratio of abundance of metabolite to parent fatty acid or precursor metabolite, independently 
for the esterified and non-esterified pools in TGRL. Overall the postprandial change (postprandial/ fasting) in 
non-esterified sEH activity index, i.e. the diol to epoxide ratio summed over all parent fatty acids measured in 
the non-esterified pool, strongly correlated with induction in VCAM-1 surface expression (Spearman ρ = 0.66 
p = 0.04, Table 4). This enhanced activity is consistent with the PLS-DA analysis that identified the change in 
diols as a key feature in discriminating pro- and anti-atherogenic TGRL. Also noteworthy in the non-esterified 
pool was sEH activity associated with ALA, and LOX activity specific to EPA metabolism, both of which corre-
lated strongly with pro-atherogenic activity. In the esterified pool, LOX activity linked to ALA, and CYP activity 
associated with EPA metabolism, were positively correlated with a pro-TGRL response. Together these results 
implicate a possible role for altered sEH and LOX activity in subjects whose TGRL elicits the greatest upregulation 
in VCAM-1 expression in inflamed HAEC.
EPA-derived metabolites and esterified diols are predictive of changes in VCAM-1 surface 
expression. We next investigated the extent to which the abundance of specific oxylipins and fatty acids 
composing postprandial TGRL were predictive of the elicited changes in ex vivo VCAM-1 surface expression. 
A multiple linear regression model was generated iteratively using 19 clusters that were comprised of all the 
oxylipins and fatty acids and exhibited similar pattern of expression in postprandial TGRL across all subjects. The 
model with the lowest Akaike’s information criteria (AIC) score was selected as the best predictor of the postpran-
dial VCAM-1 surface expression (Supplementary Table S4). The strongest model (R2 = 0.76, p-value = 0.0067) 
was composed of the two cluster components depicted by the equation in Fig. 5. The strongest positive cor-
relator with the measured ex vivo VCAM-1 surface expression was Cluster 1, which consisted predominantly 
of EPA and esterified EPA-derived metabolites (17,18-EpETE, 9-HEPE, 15-HEPE, 5-HEPE). This is in accord-
ance with the elevated EPA-specific LOX activity observed postprandially in pro-atherogenic subjects. Cluster 
2, comprised predominantly of C18-derived esterified diols (12,13-DiHOME, 9,10- DiHOME, 15,16-DiHODE, 
9,10-DiHODE), negatively correlated with VCAM-1 expression. These findings are consistent with the observa-
tions from the PLS-DA model.
Reduction in lipogenesis indices and non-esterified diols in fasting subjects are strong predic-
tors of postprandial VCAM-1 expression. Given the strong correlation of postprandial VCAM-1 expres-
sion with fasting markers of dyslipidemia, we evaluated whether the composition of TGRL in fasting subjects was 
also predictive of the postprandial VCAM-1 response. A second multiple linear regression model was generated 
iteratively using 18 clusters of oxylipins and fatty acids, identified by their similar pattern of expression in TGRL 
from fasting subjects. As above the AIC score was used to select a model that best fit measured VCAM-1 expres-
sion data (Supplementary Table S5). Three clusters emerged as strong negative correlators with VCAM-1 surface 
expression, which provided the best fit for the data (Fig. 6, R2 = 0.95, p = 0.0002). Cluster 1 consisted predom-
inantly of non-esterified diols suggesting elevated levels of sEH activity that contributes to the non-esterified 
oxylipin pool in fasting anti-atherogenic subjects. Clusters 2 and 3 were comprised of various lipogenesis indices 
and Σn-6/Σn-3, which are emerging biomarkers for dyslipidemia28. Both the fasting esterified and non-esterified 
ELOVL-6 indices (stearic acid to palmitic acid ratio) inversely correlated with VCAM-1 expression. Esterified 
Δ5D and SCD-1 and non-esterified levels of Σn-6/Σn-3 and ELOVL-2 were also inversely correlated to the 
measured VCAM-1 expression. Together, these data support the utility of these lipogenesis indices as potential 
Enzyme activity indexa Spearman’s ρ P-value
Non-esterified
Overall sEH activity 0.66 0.04*
• sEH activity (ALA) 0.83 0.003*
Overall LOX activity 0.24 0.51
• LOX activity (EPA) 0.72 0.02*
Overall CYP activity −0.32 0.36
Overall COX activity −0.21 0.56
Esterified
Overall sEH activity −0.43 0.22
Overall LOX activity 0.49 0.15
• LOX activity (ALA) 0.70 0.03*
Overall CYP activity −0.27 0.45
• CYP activity (EPA) 0.67 0.03*
Overall COX activity −0.41 0.24
Table 4. Correlation of VCAM-1 surface expression with indices of enzyme activity (n = 10). aEnzymatic 
and lipogenesis activity were estimated using TGRL (postprandial/fasting) fatty acid and oxylipin product/ 
precursor relationships, separately for esterified and non-esterified pools. *Significant difference.
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biomarkers that predict a subject’s susceptibility to CVD. Moreover, the regression analysis reveals that fasting 
indicators of metabolism reflected in the composition of TGRL strongly predict the inflammatory postprandial 
response.
Linoleic acid-derived oxylipins are regulators of tNFα-stimulated VCAM-1 expression in 
HAeC. To demonstrate that the differences in concentrations of individual oxylipins identified by our analysis 
of TGRL could directly affect endothelial inflammation, we delivered several of them as methyl esters to stim-
ulated HAEC and measured the dose response in VCAM-1 expression. The methyl ester form is readily taken 
up by cells and is analogous to the non-esterified or free form measured in TGRL. In this analysis we selected 
representative non-esterified oxylipins that contributed significantly to distinguishing pro- from anti-atherogenic 
TGRL (Fig. 4), and strongly influenced the modeled VCAM-1 expression (Figs 5 and 6). The linoleic acid metab-
olites 9-HODE and 12,13-DiHOME, which were present in relatively high abundance in TGRL and had a strong 
negative influence on the modeled VCAM-1 expression, exhibited a dose-dependent effect in reducing HAEC 
VCAM-1 expression (Fig. 7). On the other hand, the DHA metabolite19,20-DiHDoPE, which was present at 
lower abundance but was also a strong contributor to distinguishing pro-atherogenic TGRL (Fig. 4), did not itself 
Figure 5. Postprandial fatty acid and oxylipin abundance in TGRL predicts changes in VCAM-1 surface 
expression by HAEC. The model was generated iteratively from all oxylipin, fatty acids, and calculated 
lipogenesis indices, clustered based on postprandial expression levels in TGRL across all subjects. Cluster scores 
were calculated as a linear combination of abundance of each cluster constituent, and used to fit the measured 
Johnson normalized VCAM-1 expression. The strongest model for predicting VCAM-1 expression consisted of 
a combination of two clusters as depicted. Dashed lines = 95% confidence interval, =Pro-atherogenic TGRL 
and =Anti-atherogenic TGRL; n = 5.
Figure 6. Fasting fatty acid and oxylipin abundance in TGRL predicts changes in VCAM-1 surface expression 
by HAEC. The model was generated iteratively from all oxylipin, fatty acids, and calculated lipogenesis indices, 
clustered based on fasting expression levels in TGRL across all subjects. Cluster scores were calculated as a 
linear combination of abundance of each cluster constituent, and used to fit the measured Johnson normalized 
VCAM-1 expression. The strongest model for predicting VCAM-1 expression consisted of a combination of 
three clusters as depicted. Dashed lines = 95% confidence interval, =Pro-atherogenic TGRL and =Anti-
atherogenic TGRL; n = 5.
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elicit a detectable effect on VCAM-1. These data provide evidence that changes in individual oxylipins trans-
ported in TGRL could skew the nature of an inflammatory response defining an atherogenic phenotype.
Discussion
Herein we quantify the effects of metabolic stress associated with the progression of atherosclerosis, through 
direct measurement of relevant inflammatory outcomes in a monolayer of arterial endothelial cells under con-
ditions that mimic a postprandial response15. Our platform provided a means to directly link changes in the 
fatty acid and oxylipin composition of an individual’s TGRL with its inflammatory capacity measured ex-vivo 
for the first time. By characterizing TGRL before and after administration of a test meal representative of a high 
fat western diet, we have established a gauge for an individual’s acute postprandial inflammatory response15–18. 
Postprandial TGRL mediated a pro- or anti-inflammatory response unique to each subject that was marked by 
an increase or decrease in endothelial VCAM-1 receptors. The magnitude of this inflammatory response was 
strongly influenced by an individual’s fasting metabolic status, in that it correlated strongly with plasma mark-
ers of metabolic dysregulation and dyslipidemia. In response to the high fat meal challenge, TGRL character-
ized as pro- or anti-atherogenic revealed different oxylipin signatures, a key distinguishing feature of which was 
a shift in the relative abundance of non-esterified (free) diols. Pro-inflammatory TGRL was enriched in EPA 
and EPA-derived oxylipins and depleted in esterified (bound) C18-PUFA-derived diols in response to the meal, 
reflecting a putative shift in sEH and LOX activity in those subjects. A remarkable finding was the ability to model 
the measured postprandial VCAM-1 response using the relative abundance of free diols and lipogenesis indices 
measured in the fasting state. We conclude that specific changes in the composition of TGRL elicited by a high fat 
meal reflect an individual’s in vivo lipoprotein metabolism and mitigate the TGRL-induced ex vivo inflammatory 
response.
In quantifying the abundance of fatty acids of various saturation levels in TGRL we found that pro-atherogenic 
TGRL was enriched in long chain PUFA, consistent with our previous report16. Though PUFA are not the most 
abundant type of fatty acid in TGRL, by virtue of their double bonds they are readily metabolized to form oxylip-
ins, which are known to elicit potent effects on inflammation, depending upon the metabolizing enzyme, the 
position of the double bond, and the parent fatty acid. Moreover, the fatty acids and oxylipins are present in both 
esterified and non-esterified forms in lipoproteins, which could lead to differences in their processing and effects 
on inflammation10,21. Esterified fatty acids and oxylipins in lipoproteins are released into tissues after their uptake 
and lipolysis21. We previously reported that the inflammatory response to postprandial TGRL was largely depend-
ent upon their receptor-mediated uptake by HAEC18. In contrast, the non-esterified fatty acids constitute only a 
small proportion of the total fatty acid constituents in TGRL. However, free oxylipins and fatty acids in TGRL are 
more readily available upon uptake and thus may be significant mediators of endothelial inflammation. Our data 
Figure 7. 9-HODE and 12,13-DiHOME reduce VCAM-1 surface expression in TNFα-stimulated HAEC. 
Representative methyl esters of oxylipins identified as contributing significantly to distinguishing a 
pro- atherogenic phenotype were delivered to TNFα-stimulated HAEC (0.3 ng/ml, 4hrs). 9-HODE and 
12,13-DiHOME reduced VCAM-1 surface expression, whereas 19, 20-DiHDoPE did not alter VCAM-1 surface 
expression relative to TNFα. *p < 0.05, **p < 0.005, ***p < 0.0005, ****p < 0.0001 by one-way ANOVA 
followed by Dunnet’s post-test. n = 3–4.
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points to the enrichment of non-esterified PUFA and oxylipins in pro-atherogenic TGRL, consistent with our 
previous analysis16. We proposed that the oxylipin metabolites constituting TGRL are bioactive and can in part 
account for the relative atherogenicity of these particles by altering endothelial inflammation.
We found that an increase in the abundance of certain vicinal (1,2)-diols, including non-esterified 
9,10-DiHOME, 12,13-DiHOME, and esterified 19,20-DiHDoPE, were among the strongest discriminators of 
a pro-inflammatory response to postprandial TGRL. Diols are downstream products of epoxides enzymatically 
converted by sEH10. sEH inhibition is associated with anti-inflammatory and vascular relaxation properties 
mediated by elevated epoxides such as EETs and EpOMEs29. For example, 11,12-EpETrE reduced TNFɑ-induced 
VCAM-1 surface expression in HAEC30. Treatment with sEH inhibitors has also been reported to lower systemic 
inflammation in a mouse model of septic shock31, and to reduce atherosclerosis in ApoE null mice32. Another 
study observed an increase in sEH-derived diols and LOX-derived HODEs in the atherosclerotic plaques of rab-
bits33. In the current study, we observed enhanced sEH and LOX activity in dyslipidemic subjects after the high 
fat meal challenge. However, a higher relative abundance of non-esterified diols of C20- and C22-PUFA which 
were depleted postprandially was a defining feature of fasting anti-atherogenic TGRL. Our analysis consistently 
revealed a shift in the levels of diols in TGRL as markers of an endothelial inflammatory response. However, 
additional studies are needed to determine whether these diols themselves mediate the inflammatory response 
in HAEC, or rather reflect a shift in metabolism away from an overall anti-inflammatory state that involves 
cross-talk with other pathways.
This study further revealed enrichment in C18-derived midchain alcohols in the TGRL of dyslipidemic 
subjects. Moreover, a significant positive correlation was observed between the calculated postprandial shift in 
EPA-specific LOX activity and VCAM-1 expression. Although midchain alcohols are products of LOX metab-
olism, they can also be derived from auto-oxidation processes associated with oxidative stress20. As we did not 
directly measure the hepatic activity, the elevated LOX index may also reflect auto-oxidation within subjects. 
However, in monitoring markers of auto-oxidation within our samples, we found them to be expressed at low 
levels, and to not differ significantly between the pro- and anti-atherogenic groups. The postprandial abun-
dance of esterified EPA and EPA-derived oxylipins (including midchain alcohols) were positive predictors for 
TGRL-induced VCAM-1 expression by HAEC. Additional studies are needed to determine whether the observed 
postprandial enrichment of EPA-derived oxylipins that mark pro-TGRL are themselves proactive mediators of 
inflammation.
Establishing causation for a single oxylipin in the context of a shifting oxylipin profile in the lipoprotein pools 
of any individual is not trivial. Indeed, an advantage of our approach is the demonstration of the functional 
importance of an individual’s mixture of oxylipins and their potential capacity to skew the inflammatory response. 
Since cells in vivo are exposed to a suite of fatty acids, oxylipins, and other metabolites present in lipoproteins 
which could have opposing effects on inflammation, characterizing the integrated response to the native oxylipin 
profile and evaluating correlative trends with inflammatory response ex-vivo provides physiological relevance. 
Nevertheless, herein we demonstrate that individual oxylipins identified by our analysis of TGRL could directly 
affect endothelial inflammation (Fig. 7). Specifically, we found that several oxylipins derived from LA that con-
tributed negatively to the modeled VCAM-1 expression in fact dose-dependently decreased VCAM-1 expression 
alone. On the other hand, representative oxylipins that contributed positively in distinguishing pro-atherogenic 
TGRL had a neutral effect when tested alone. These data support the assertion that although isolated oxylipins 
may elicit an effect on inflammation, their combined effects and variable abundance in TGRL are more represent-
ative of the in vivo influence on inflammation. One possibility is that the expression patterns we see comparing 
the different responses to TGRL represent more of a shift away from an overall anti-inflammatory state to a more 
neutral or permissive one, rather than being overtly inflammatory. Alternatively, they may reflect a feedback 
response to the high fat meal in hypertriglyceridemic subjects to mitigate inflammation.
Since subjects consumed an identical high fat meal, differences in the postprandial response, especially as 
they correlate with markers of fasting metabolism, are likely attributable to altered liver metabolism. Though 
we did not directly measure hepatic enzyme activities as markers of liver function, elevated CRP levels have 
been associated with higher alkaline phosphatase and alanine aminotransferase activities in metabolic syndrome 
subjects. The magnitude of elevated CRP observed at fasting and postprandial in pro-atherogenic subjects could 
therefore indirectly point to elevated liver function26,27. A finding of the current study was that fasting measures 
of lipogenesis activity (SCD-1, ELOVL-6, and Δ5D) inversely correlated with the measured endothelial VCAM-1 
expression. The liver metabolizes LA and ALA derived from the diet to produce downstream long chain PUFAs 
using ELOVL and desaturase enzymes. These enzymes also catalyze the production of MUFAs from SFA, and 
elongate SFAs. Impairment or hyperactivity of these enzymes is associated with altered lipid metabolism and 
disease states such as type 2 diabetes and hypertriglyceridemia, both risk factors for CVD34–36. We observed an 
overall reduction in ELOVL-6 activity in response to the high fat meal challenge, particularly in pro-atherogenic 
subjects, which implies impairment of elongation or saturation of palmitic acid. Elevated levels of palmitic acid 
are strongly associated with a sedentary lifestyle and hypertriglyceridemia37. In a recent ten-year longitudinal 
study, ELOVL-6 and Δ5D activity were significantly reduced in obese subjects who developed dyslipidemia28. 
Other reports correlated impaired Δ5D activity to high BMI, CRP, and elevated triglyceride and CVD related 
mortality34,38. Consistent with these studies, we report that Δ5D and ELOVL-6 activity inversely correlated with 
endothelial VCAM-1 surface expression, a direct measure of inflammation and marker of atherosclerosis14. These 
findings support the utility of measures of lipogenesis and lipid metabolism (sEH, LOX, Δ5D, ELOVL-6) in iden-
tifying subjects in a state of metabolic dysregulation associated with greater cardiovascular risk.
We have previously reported that the upregulation of TGRL-induced VCAM-1 is in part signaled via the 
endoplasmic reticulum (ER) stress response that promotes increased activity of the transcription factor interferon 
regulatory factor 1 (IRF-1)16,18. This mechanism distinguishes VCAM-1 expression from ICAM-1, which is inde-
pendent of both IRF-1 and ER stress. By extension the varying oxylipin constituents transported in TGRL may 
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directly induce downstream activation or inhibition of ER stress and subsequent increase or decrease in VCAM-1 
surface expression. It is established that an excessive load of fatty acids can induce a state of ER stress in hepato-
cytes, macrophages and adipocytes39. ER is the hub of lipogenesis activity in cells and ER stress correlates strongly 
with obesity and CVD. Inhibition or knock-down of sEH can reduce high fat diet or pharmacologically induced 
ER stress in mouse models40,41. Individual oxylipins including 9-HODEs and 12/15-HETEs induced ER stress in 
macrophages and adipocytes, respectively42,43. 12(S)-HETE was shown to directly enhance the monocyte adhe-
sion in HAEC44. Further, pharmacological inhibition of LOX, COX, CYP, and sEH enzymes have consistently 
demonstrated that perturbing oxylipin metabolism can alter systemic inflammation. For example, knock-out of 
12/15 LOX in Apo-E null mice resulted in a 95% reduction in monocyte arrest within the aorta45. These observa-
tions motivate a need for further investigation to establish a causative role for enrichment in individual oxylipins 
within TGRL in modulating ER stress responses that promote endothelial inflammation.
Herein we develop regression models to predict the relative atherogenicity of an individual’s postprandial 
TGRL based on the oxylipins present in these lipoproteins. The models were generated from a cohort of subjects 
whose TGRL elicited the greatest modulation in VCAM-1 expression. Validation of these models in a larger 
independent cohort of subjects that includes patients with established metabolic syndrome and coronary artery 
disease, would ultimately demonstrate the predictive potential for gauging cardiovascular risk and disease pro-
gression over time. This approach could also prove useful in quantifying the effects of dietary intervention, stat-
ins, or other lipid-lowering therapies, by providing direct real-time measures of an individual’s lipid metabolism 
and inflammatory status.
The aim of this study was to shed light on the variable inflammatory response in individuals elicited by an 
identical meal rather than to compare the response to meals of different fatty acid composition. Thus, we chose 
a test meal that we have used to elicit a variable postprandial endothelial inflammatory response in multiple 
studies15,16,18. The meal is high in saturated fat and calories, and the cholesterol levels are above recommended 
intake for healthy diets. However, the meal is representative of a fast food breakfast meal not uncommon in the 
Western diet. Since this study identifies differences in the fatty acid composition of TGRL (particularly PUFA and 
PUFA-derived oxylipins) that correlate strongly with the nature of an inflammatory response, we envision future 
controlled dietary intervention studies that vary the fatty acid composition of the meal (e.g. replacing SFA with 
PUFA), or supplement with n-3 PUFA, and quantify the postprandial response.
Previous experience shows that the differential VCAM-1 expression observed in the postprandial state is 
not induced by fasting TGRL15. One possible explanation is that the fasting state is primarily anti-inflammatory 
among most subjects, though it can reflect a different baseline on which a postprandial insult superposes to 
amplify differences in the inflammatory response of an individual. Consistent with this is the observation that the 
postprandial increase in subjects’ plasma markers CRP and sVCAM predicted the magnitude of the inflammatory 
response to TGRL measured ex vivo. Thus, this technique has the potential to be employed to discriminate patient 
populations who do not present elevated levels of conventional clinical risk factors but are still at high risk for 
atherosclerotic CVD. It is also noteworthy that hypertriglyceridemic subjects exhibit lower clearance of TGRL 
particles and higher accumulation of lipoproteins. In this regard, the differences we have observed in the oxylipin 
composition between pro- and anti-TGRL may exacerbate an inflammatory response in endothelium exposed to 
these particles for a prolonged period.
In conclusion, we have identified a characteristic oxylipin signature in postprandial TGRL that distin-
guishes an acute pro- versus anti-inflammatory endothelial response in subjects consuming an identical high 
fat meal. Dyslipidemic subjects were uniquely characterized by a shift in sEH and LOX activity, and produced 
pro-atherogenic TGRL, postprandially enriched in EPA-metabolites and depleted in C18-PUFA-derived esteri-
fied diols. In contrast, normolipidemic subjects exhibited higher indices of fasting lipogenesis activity, and pro-
duced anti-atherogenic TGRL enriched in esterified C18-PUFA-derived diols, but depleted in non-esterified diols 
after the high fat meal challenge. These results implicate a role for the fatty acids and oxylipins constituting TGRL 
in mediating a pro- or anti-atherogenic endothelial phenotype. We further conclude that lipoproteins such as 
TGRL can serve as a depot for fatty acids and oxylipins, and propose that these bioactive fatty acid metabolites 
transported in TGRL could act remotely to directly modulate an endothelial inflammatory response.
Methods
Human subject recruitment and characterization. Human subjects (N = 39) were recruited according 
to an Institutional Review Board approved protocol at the University of California, Davis in accordance with the 
Helsinki principles and institutional guidelines and regulations. Informed consent was obtained from all research 
participants. The subjects varied from normal lipidemic to dyslipidemic, but did not have hypertension or ele-
vated fasting glucose, and thus were not overtly characterized as having metabolic syndrome (Supplementary 
Table S1). Subjects were recruited without restriction to age, gender, race, or socioeconomic status. Exclusion 
criteria include subjects with kidney disease, liver disease, untreated thyroid dysfunction and ongoing hormone 
replacement therapy, omega-3 (n-3) fatty acid (i.e. fish oil) supplementation, lipid lowering medications (i.e. 
statins), excessive or prolonged use of alcohol, and consumption of nonsteroidal anti-inflammatory drugs or caf-
feinated beverages within 12 hrs of blood collection. Venipuncture was performed to collect 20 ml of blood after 
an overnight fast and again 3.5 hrs after consuming a test meal. The meal was a standardized fast food breakfast 
high in saturated fatty acid content and calories (Supplementary Table S3). Blood samples were immediately 
centrifuged (1932g, 10 min, 25 C) to obtain plasma. Plasma aliquots (both fasting and postprandial) were sent 
to the UC Davis Medical Center clinical laboratory for standard lipid panels, including triglycerides (TG), total 
cholesterol (TC), and high-density lipoprotein cholesterol (HDL). Low density lipoprotein cholesterol (LDL) was 
calculated using Friedewald equation. In some cases, LDL was not reported as the postprandial spike in triglyc-
erides rendered the equation unusable. Plasma glucose and ApoB levels were also measured. A panel of cytokines 
and other inflammatory markers in plasma, including interleukin (IL)-1α, IL-1β, IL-6, IL-10, TNFα, IL-17A, 
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soluble VCAM-1 (sVCAM-1), soluble ICAM-1 (sICAM-1), c-reactive protein (CRP) and interferon γ (IFNγ), 
were measured using a multiplex immune assay (V-Plex Meso Scale Discovery).
tGRL isolation. Plasma was spiked with 1x antibiotic/ antimycotic (GIBCO). Density-based ultracentrif-
ugation (40,000 RPM, 18hrs, 4 C) was used to isolate TGRL particles from plasma (ρ < 1.0063 g/ml) using a 
Beckman XL-90 ultracentrifuge. ApoB content was quantified using an ELISA kit (ALERCHEK) that measures 
both ApoB48 and ApoB100. In the fasting state TGRL consists of mainly ApoB100-containing very low-density 
lipoproteins (VLDL), whereas the postprandial TGRL is a mixture of VLDL and ApoB48-containing chylomi-
crons. ApoB concentrations were used to normalize the TGRL quantity for inflammatory characterization of 
HAEC and for mass spectrometry analysis. TGRL samples were characterized within 7 days of isolation or were 
aliquoted and frozen for future use. All samples were immediately flushed with nitrogen gas upon collection 
to prevent auto-oxidation. The extent of oxidation in the samples was monitored by tracking concentrations of 
9-HETE, total TriHOME and F2-isoprostanes, which did not differ significantly between experimental groups.
tGRL characterization. Human aortic endothelial cells (HAEC), passage 6–8 (Genlantis, lot #2228 derived 
from a 21-yr-old female, and lot #7F4409 from a 34-yr-old male), were cultured with endothelial cell growth 
media-2 (EGM-2, Lonza) supplemented with 1x antibiotic/ antimycotic (GIBCO). Cells were seeded on tissue 
culture plates (Falcon) and proliferated to form a 85–95% confluent monolayer. HAEC were then incubated 
with postprandial TGRL (10 mg/dl ApoB) for 4 hrs in the presence of TNFα (0.3 ng/ml, the calibrated EC50 for 
CAM upregulation, R&D). HAEC were dissociated from the tissue culture plate using 1 mM EDTA (10 mins, 
Sigma), and stained with phycoerythrin-conjugated VCAM-1 antibody (BD Biosciences no. 555647, 10 µl per 
100,000 cells) and Alexafluor 488-conjugated intercellular adhesion molecule-1 (ICAM-1) antibody (Biolegend 
no. 322714, 5 µl per 100,000 cells). VCAM-1 and ICAM-1 surface expression were measured using flow cytometry 
(Attune NXT). To account for day-to-day cell variability in HAEC response, CAM expression is reported as % 
change from TNFα stimulation alone. Based on previous studies, TGRL eliciting an increase in VCAM-1 expres-
sion ≥10% are characterized as pro-atherogenic, and those that decrease VCAM-1 by ≥10% as anti-atherogenic, 
as these changes correlate strongly with mononuclear cell recruitment.
Quantification of fatty acids and oxylipins in fasting and postprandial TGRL. Non-esterified fatty 
acids (NEFA) and oxylipins, along with total fatty acids (TFA) and alkaline stable oxylipins were quantified using 
mass spectrometry: ultra-performance liquid chromatography mass spectrometry (UPLC-MS/MS) for oxylip-
ins, and gas chromatography-mass spectrometry (GC-MS) for FA. For simplicity, since the non-esterified pools 
account for a minor component of the total pool, the total fatty acid and total alkaline stable oxylipin pools are 
referred to as esterified lipids for the remainder of this manuscript. The abundance of oxylipins was reported 
as pmol/mg ApoB and fatty acids as nmol/mg ApoB. Lipids were isolated using a liquid-liquid extraction with 
cyclohexane/isopropanol/ammonium acetate after enrichment with a suite of deuterated and rare compounds 
used as analytical surrogates46,47. Fatty acids were transformed into methyl esters, using either TMS-diazomethane 
or methanolic transesterification for NEFA and TFA, respectively. The fatty acid methyl esters were separated 
on 30 m x 0.25 mm, 0.25 µm DB-225ms (Agilent Technologies), detected with a 5973 A mass selective detec-
tor (Agilent Technologies) using electron impact ionization and selected ion monitoring, and quantified against 
authentic standards. Results were corrected for the recoveries of analytical surrogates as previously described47. 
Non-esterified oxylipins were isolated directly from TGRL solution in PBS using solid phase extraction. Esterified 
oxylipins were transformed into oxylipin free acids by base hydrolysis, and isolated by subsequent hydrophilic/
lipophilic interaction solid phase extraction. Non-esterified and alkaline stable esterified oxylipins were analyzed 
by UPLC-MS/MS using negative mode electrospray ionization and multi-reaction monitoring on a Sciex 4000 
QTRAP47. Concentrations were calibrated using analytical standards as previously reported47,48.
Characterization of oxylipin response. Oxylipins were synthesized in methyl esterified forms dissolved 
in ethanol by the Hammock Lab (UC Davis). They were delivered to TNFα (0.3 ng/ml) stimulated HAEC at doses 
ranging from 0.1–100 nM for 4hrs. Change in VCAM-1 surface expression in HAEC from vehicle control was 
quantified by flow cytometry.
enzyme activity index estimation. Fatty acid and oxylipin data were categorized into non-esterified and 
esterified fatty acid pools and metabolites were grouped by their parent fatty acids. An activity index for each par-
ent fatty acid was calculated based on product to substrate abundance ratios according to the following equations:
= Σ +LOX index (midchain alcohols ketones)/parent fatty acid (1)FA FA
CYP index (epoxides)/parent fatty acid (2)FA FA= Σ
= Σ ΣsEH index (diols)/ (epoxides) (3)FA FA FA
An overall activity index was also estimated using the overall product to substrate ratio summed across all 
measured fatty acids. Analyses were then conducted on the postprandial to fasting ratio of these calculated 
enzyme activities.
Indices of lipogenesis were calculated as a ratio of the measured abundance of fatty acid product to precursor 
in the fasting and postprandial plasma or TGRL: stearoyl-CoA desaturase-1 (SCD-1, C16:1n-7/C16:0), SCD-C18 
(C18:1n-9/C18:0), SCD-C16 (C16:1n-9/C16:0), delta 5 desaturase (Δ5D, C20:4n-6/C20:3n-6), elongation of very 
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long fatty acid-6 (ELOVL-6, C18:0/C16:0), ELOVL-2 (C22:5n-3/C20:5n-3). The ratio of n-6 to n-3 PUFA was 
calculated across all measured PUFA (Σn-6/Σn-3).
statistical analysis. All statistical analyses were performed using JMP Pro 13 software. Fatty acid and 
oxylipin abundance data were Johnson transformed and checked for normality using the Shapiro-Wilk test. 
Outliers were assessed based on an interquartile range calculated per metabolite. Outliers were excluded if inter-
quartile range <Q1 – (3 x interquartile range) or >Q3 + (3 x interquartile range). Missing values were imputed 
via a multivariate approach. Undetectable levels of metabolites were substituted by 0.5 x the lowest detected 
expression level measured for that specific metabolite.
To assess differences in FA and oxylipin composition in TGRL as a function of the meal, TGRL-induced 
inflammatory phenotype, and interaction between the two factors, a two-factor analysis of variance (ANOVA) 
was performed. P-values were corrected for multiple testing using a Benjamini-Hochberg false discovery rate 
(FDR) approach. Likewise, a two-factor ANOVA and FDR was used to assess differences in plasma inflammatory 
markers.
The Pearson method was used to correlate the change in VCAM-1 surface expression with clinical biomarkers 
in the full subject cohort (N = 39), since normality was satisfied. In the smaller set of subjects chosen for metabo-
lomics analysis (n = 10), a non-parametric Spearman rank method was used to assess correlations between CAM 
expression and subject characteristics, plasma lipid, plasma cytokines or TGRL constituents.
To identify the shift in fatty acid and oxylipin constituents differentiating pro- and anti-atherogenic TGRL, a 
partial least squares discriminant analysis (PLS-DA) was performed. Postprandial abundance data were adjusted 
to the fasting values (postprandial/ fasting) for each subject (n = 10). This approach reduced the multivariate data 
for projection on the 2 coordinate axes resulting in the maximum separation between the pro- and anti-TGRL 
groups based on fatty acid and oxylipin abundance. The scores plot depicts the separation between the samples 
characterized for their relative atherogenicity, while the loadings plot superposes the metabolites that contribute 
to the maximum variability between the two groups. Variable importance in projection (VIP) scores the relative 
contribution of each metabolite to the separation visualized in the scores plot. Metabolites with a VIP score of 
over 1.1 were considered to contribute significantly to the separation. The leave-one-out method was used to 
cross-validate the model. Next, the 22 oxylipins identified as the significant contributors to the PLS-DA model 
were clustered by expression pattern using the JMP 13 Pro cluster variable algorithm. The fasting to postprandial 
change of the most representative metabolite in the cluster, i.e. that for which the expression correlated most 
strongly to the principal component of the cluster, was graphed in order to visualize the change in abundance of 
the metabolite in response to the meal.
Regression modeling. A stepwise linear regression modeling approach was used to fit metabolite expression 
data to measured change in VCAM-1 surface expression in HAEC. Metabolites were first clustered to account for 
collinearity and maintain independence between the input variables in the model. A cluster variable algorithm in 
JMP Pro 13 was used to group metabolites based on the correlation of their expression levels across all subjects, 
using the fatty acids, oxylipins, and lipogenesis indices as inputs. This resulted in 19 clusters for the postprandial 
case, and 18 clusters for the fasting case. Each cluster was reduced to a representative cluster component49 that 
was an input into the iterative regression model. To satisfy the linearity requirement, VCAM-1 expression was 
Johnson transformed50. The regression model fit the response variable (y, VCAM-1 expression), using stepwise 
addition of cluster components as independent input variables (xi). The Akaike’s information criteria (AIC) and 
Beyesian information criteria (BIC) scores were used in model optimization with a goal of minimizing the num-
ber of independent terms. The addition of a term was considered to result in a stronger model if it improved the 
p-value and R2 while also reducing the AIC score by 2 or more51,52. The resulting model can be expressed by the 
following equation, where b0, b1, b2, b3, b4, …, bx are coefficients corresponding to each input variable (cluster):
= + + + …. ++y b b x b x b x b x b x (4)0 1 1 2 2 3 3 4 4 i i
Data Availability
The raw data generated by the study are provided as a supplementary data file to accompany the manuscript 
submission.
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